Newron Pharmaceuticals SpA - Company Profile
Powered by 
All the sales intelligence you need on Newron Pharmaceuticals SpA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Newron Pharmaceuticals SpA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Newron Pharmaceuticals SpA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Newron Pharmaceuticals SpA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 12 Nov 2021 | Newron Pharmaceuticals SpA Enters Phase II/III Clinical Trial Agreement with Hippocrates Research Srl for evenamide (GDCT0449441) | Contract Service Agreement |
Newron Pharmaceuticals SpA
|
Hippocrates Research Srl
|
| 06 Sep 2021 | Newron Pharmaceuticals SpA Enters Phase II/III Clinical Trial Agreement with CliniRx Research Pvt Ltd for evenamide (GDCT0417350) | Contract Service Agreement |
Newron Pharmaceuticals SpA
|
CliniRx Research Pvt Ltd
|
| 26 Apr 2021 | Newron Pharmaceuticals SpA Enters Phase II Clinical Trial Agreement with CliniRx Research Pvt Ltd for evenamide (GDCT0418514) | Contract Service Agreement |
Newron Pharmaceuticals SpA
|
CliniRx Research Pvt Ltd
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer